SEBI Greenlights 5 IPOs: Prestige Estates, Anand Rathi, Epack Prefab, SSF Plastics & Gujarat Kidney Prep for Market Debuts

Regulators just handed out golden tickets—and these companies are rushing to the IPO party.
SEBI’s stamp of approval means five firms—Prestige Estates Projects, Anand Rathi, Epack Prefab, SSF Plastics, and Gujarat Kidney and Super Speciality—are cleared to tap public markets. Cue the confetti cannons.
Why this matters: Fresh IPOs mean fresh capital… and fresh hype cycles. Investors get new toys; companies get liquidity. Everybody wins (until the lockup periods expire).
The cynical take? More IPOs = more exit liquidity for early backers. But hey—someone’s gotta keep the secondary market interesting.
₹750-cr IPO from Anand Rathi
Anand Rathi Share and Stock Brokers is planning to launch ₹745 crore IPO, which is entirely a fresh issue. Anand Rathi Group’s brokerage arm, Anand Rathi Share and Stock Brokers, has refiled its DRHP with SEBI. Earlier, it had filed its DRHP in December 2024. Proceeds worth ₹550 crore will be used to fund the company’s long-term working capital requirements and general corporate purposes, it said in a DRHP.
Epack Prefab public issue
Epack Prefab Technologies’ IPO consists of fresh issues worth ₹300 crore and an offer-for-sale of up to one crore shares by promoter group and selling shareholders. The company will use the funds for setting up a new manufacturing facility at Ghiloth Industrial Area in Alwar, Rajasthan, expansion of the existing manufacturing facility at Mambattu in Andhra Pradesh, payment of debt and for general corporate purposes.
Gujarat Kidney IPO
Gujarat Kidney and Super Speciality’s offer is entirely a fresh issue of 2.2 crore shares. It provides integrated healthcare services, with a focus on secondary and tertiary care. Proceeds of the IPO will be used for proposed acquisition of Parekhs Hospital in Ahmedabad, part-payment of purchase consideration for the already acquired Ashwini Medical Centre, setting up a new hospital in Vadodara, and buying robotics equipment for the hospital in Vadodara. Besides, the company will also use fresh funds for debt repayment, funding inorganic growth through unidentified acquisitions and general corporate purposes.
SSF Plastics’ public issue
SSF Plastics India’s ₹550 crore IPO consists of fresh issue worth ₹300 crore and an OFS of ₹250 crore by promoters and promoter group entities. Proceeds from the fresh issue will be utilised for payment of debt, funding capital expenditure requirements for purchase of plant and machinery and for general corporate purposes.
Published on August 6, 2025